American Journal of Microbiological Research
ISSN (Print): 2328-4129 ISSN (Online): 2328-4137 Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
American Journal of Microbiological Research. 2019, 7(2), 37-44
DOI: 10.12691/ajmr-7-2-1
Open AccessArticle

Antibiotic Resistance Patterns among Gram-negative Bacteria from Patients with Urinary Tract Infection at a Healthcare Center in Ekiti-State, Nigeria

Ajayi A. O.1, , Osanyinlusi S. A.1, Ogeneh B.1, Ojerinde O. A.2 and Oladeji S. J.1

1Department of Microbiology, Federal University Oye-Ekiti, Ekiti-State, Nigeria

2Laboratory Unit, University Health Center, Federal University Oye-Ekiti, Ekiti-State, Nigeria

Pub. Date: March 22, 2019

Cite this paper:
Ajayi A. O., Osanyinlusi S. A., Ogeneh B., Ojerinde O. A. and Oladeji S. J.. Antibiotic Resistance Patterns among Gram-negative Bacteria from Patients with Urinary Tract Infection at a Healthcare Center in Ekiti-State, Nigeria. American Journal of Microbiological Research. 2019; 7(2):37-44. doi: 10.12691/ajmr-7-2-1


Urinary Tract Infections (UTIs) are huge health burden. This study determined the current incidence of antibiotic resistance among Gram-negative bacteria from patients with UTI at a health center in Ado Ekiti, Nigeria. One hundred and twenty two mid-stream urine samples were collected and cultured. Sixty-four samples (52.4%) grew significant bacteria. Gram-negative bacterial colonies were picked per plate, identified and tested for susceptibility to the following antibiotics: Ertapenem (10µg), meropenem (10µg), ceftazidime (30µg), ceftriaxone (30µg), gentamicin (10µg), ampicillin (10µg), tetracycline (30µg), norfloxacin (10µg) and pefloxacin (5µg). Thirty-nine isolates were selected for extended spectrum beta-lactamase production using the double disk synergy test. All the bacteria were tested for biofilms and haemolysis. Sixty-four Gram-negative bacterial isolates were recovered from 64 samples. The bacteria recovered included K. pneumonia, K. oxytoca, P. vulgaris, E. coli, P. mirabilis and P. aeruginosa. Overall, the bacteria showed the highest resistance to ampicillin 60/64 (94.5%) and least resistance to meropenem 18/64 (28.1%). All the bacteria tested for ESBL production were confirmed as ESBL producers. Twenty-two (34.3%) isolates were strong biofilm producers while 19 isolates were haemolytic (29.7%). These findings have serious implications to medical care and public health. Strict antibiotic stewardship should be enforced.

Gram-negative bacteria UTIs antibiotic resistance biofilm

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Omonigho, S. E., Obasi, E. E. and Akukalia, R. N. (2001). In-vitro Resistance of Urinary Isolates of Escherichia coli and Klebsiella species to Nalidixic Acid. Nig. Jour Microbiol. 2001; 15(1): 25-29.
[2]  Flores-Mireles, A., Walker, J. N., Capron, M. and Hultgreen, S. J. (2015). Urinary tract infections: epidemiology, mechanisms of infections and treatment options. Nature Rev Microbiol 13: 269-284.
[3]  Stamm, W. E. and Norrby, S. R. (Urinary tract infections: disease panorama and challenges. Jour of Infect Dis 2001; 183 (Suppl 1): S1-S4.
[4]  Tansarli GS, Athanasiou S and Falagas ME. Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa. Antimicroba Agents and Chemother 2013; 57(8): 3628-3639.
[5]  Anozie OB, Lawani OL, Esike CUO, Mma E and Ajah LO. Prevalence and Common Microbial Isolates of Urinary Tract Infection in Pregnancy; A Four Year Review in a Tertiary Health Institution in Abakaliki, South-East Nigeria. Amer Jour Clin and Med Res 2016; 4(2), 25-28.
[6]  Leski TA, Taitt CR, Bangura U, Stockelma, MG, Ansumana R and Cooper WH. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone. BMC Infect Dis 2016; 16:167.
[7]  Davidson S, Edwards CRW and Bouchier IAO. Principles and practice of medicine. Cambridge Press; 1989. p. 661.
[8]  Ebie MY, Kandakai-Olukemi YT, Ayanbadejo J and Tanyigna KB. 2001. Urinary Tract Infections in a Nigerian Military Hospital. Nig Jour Microbiol 15 (1): 31-37.
[9]  Oladeinde BH, Omoregie R, Olley M and Anunibe J. Urinary tract infection in a rural community of Nigeria. North Amer Jour Med Sci 2001; 3: 75-7.
[10]  Agbagwa OE and Ifeanacho EJU. The Prevalence of UTI Pathogens in Urine Specimen Obtained from a Hospital in Rivers State Nigeria. Jour of Microbiol Res 2015; 5(5): 143-148.
[11]  Obiogbolu CH, Okonko IO, Anyamere CO, Adedeji AO., Akanbi AO, Oguu AA, Ejembi J and Faleye TOC. Incidence of UTIs among pregnant women in Akwa metropolis SE Nigeria. Scientific Res and Essays 2012; 4(8): 820-824.
[12]  Okonko IO, Ijandipe, L. A., Ilusanya, O. A., Donbraye-Emmanual, O. B., Ejembi, J. A., Udeze, A. O., Egun, O. B., Fowatade, A. and Nkang, A. O. (2009). Incidence of UTI among pregnant women in Ibadan, Southwest Nigeria. African Journal of Biotechnology 2009; 8(23): 6649-6657.
[13]  Aiyegoro OA, Igbinosa OO, Ogunmwuyi IN, Odjadare EE, Igbinosa OE and Okoh AI. 2007. Incidence of urinary tract infections amng children and adolescents in Ile-Ife, Nigeria. African Jour Microbiol Res 2007; 013-019.
[14]  Hanna-Wakim RH, Ghanem ST, El Helou MW, Khafaja SA, Shaker RA, Hassan SA, Saad RK, Hedari CP, Khinkarly RW, Hajar FM, Bakhash M, El Karah D, Akel IS, Rajab MA, Khour, and Dbaib, GS. Epidemiology and characteristics of urinary tract infections in children and adolescents. Frontiers Cellular Infection and Microbiology 2015; 5: 45.
[15]  Tandogdu Z. and Wagenlehner FM. Global epidemiology of Urinary tract infections. Curr Opinion Infect Dis. 2016; 29(1): 73-79.
[16]  Zalmanovici TA, Green H, Paul M, Yaphe J and Leibovici L. Antimicrobial agents for treating uncomplicated urinary tract infection in women.In Zalmanovici Trestioreanu Anca "Cochrane Database of Systematic Reviews". Cochrane Database of System Rev 2010; 10(10): CD00.7182.
[17]  Dash M, Padhi S, Mohanty I and Parida B. Antimicrobial resistance in pathogens causing urinary tract infections in a rural community of Odhisa, India. Jour of Fam Comm Med 2013; 20 (1): 20-26.
[18]  Picozzi SC, Casellato S, Rossini M, Paola G, Tejada M, Costa E, Carmignani L. Extended-spectrum β-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: urologist should act in time. Urol Ann 2014; 6:107-112.
[19]  Bjorkman I, Berg J, Viberg N and Lundborg, C. S. Awareness of antibiotic resistance and antibiotic prescribing in UTI treatment: A qualitative study among primary care physicians in Sweden. Scand Jour Prim Healthcare 2013; 31: 50-55.
[20]  Cerceo E, Deitelzweig SB, Sherman BM. and Ami, AN. Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options. Microb.Drug Resist 2016; 22(5): 412-31.
[21]  Kurtaran B, Candevir A, Tasova Y, Kibar F, Inal AS, Komur S. and Aksu, H. S. Antibiotic resistance in community-acquired urinary tract infections: prevalence and risk factors. Medical Science Monitoring 2010; 16(5): 246-51.
[22]  Otajevwo FD and Amedu SS. 2015. Community acquired urinary tract infections prevalence in a tertiary institution based in Edo State, Nigeria. Glob Jour Med Res 15(3):11.
[23]  Barrow GI and Feltham RKA. Cowan and Steel manual for identification of medical bacteria. 2003: 94-150.
[24]  CLSI. Performance Standards for Antimicrobial Susceptibility Testing, Twentieth Informational Supplement. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2015.
[25]  Tajbakhsh E, Ahmadi P, Abedpour-Dehkordi E, Arbab-Soleimani N and Khamesipour F. Biofilm formation, antimicrobial susceptibility, serogroups and virulence genes of uropathogenic E. coli isolated from clinical samples in Iran. Antimicrob Resis and Infect Cont 2016; 5: 11.
[26]  Ruiz J, Simo, K, Horcajada JP, Velasco M, Barranco M, Roig G, Moreno-Martínez A, Martínez JA, Jiménez de Anta T, Mensa J and Vila J. Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. Jour. of Clin Microbiol 2002; 40 (12): 4445-9.
[27]  Erdem I, Kara R, Ardic E, Elbasan O, Mutlu R and Topaja AE. Community acquired lower urinary tract infections: Etiology, antimicrobial resistance and treatment results in female patients. Jour of Global Infect Dis 2018; 10(3): 129-132.
[28]  Cunha MA, Assunção GL, Medeiros IM and Freitas, M. R. Antibiotic resistance patterns of urinary tract infections in a northeastern Brazilian capital. Revista do Instituto de Medicina Tropical de Sao Paulo 2016; 58: 2.
[29]  Munkhdelger Y, Gunregjav NA, Dorjpurev A, Juniichiro N and Sarantuya J. Detection of virulence genes, phylogenetic group and antibiotic resistance of uropathogenic Escherichia coli in Mongolia. Jour of Infect Dev Countries 2017; 11(1): 51-57.
[30]  Ali I, Rafaque Z, Ahmed S, Malik S and Dasti JI. Prevalence of multi-drug resistant uropathogenic E. coli in Potohar region of Pakistan. Asia Pacific Jour Trop Med 2016; 6(1): 60-66.1.
[31]  Aliyu S. Carbapenemase producing Gram-negative bacteria: An emerging threat to healthcare in Africa. Annals of Nig Med 2013; 7: 1-2.
[32]  Anibijuwon II, Gbala, ID, Adebisi OO. Carbapenem-Resistant Enterobacteriaceae among In-Patients of Tertiary Hospitals in Southwest, Nigeria. Notulae Scientia Biologicae 2018; 10(3): 310-317.
[33]  David H, Howard R, Scott D, Packard R and Jones D. The Global Impact of Drug Resistance. Clin Infect Dis 2003; 36: S4-S10.
[34]  Yusuf I, Rabiu AT, Haruna M and Abdulahi SA. Carbapenems resistant Enterobacteriaceae (CRE) in intensive care units and surgical wards of hospitals with no history of of carbapenems usage in Kano, Northwest Nigeria. Niger Jour of Microbiol 2015; 27(1). 2612-2618.
[35]  Bidell MR, Palchak M, Mohr J and Lodise TP. Fluoroquinolone and third-generation cephalosporin resistance among hospitalized patients with urinary tract infections due to Escherichia coli: do rates vary by hospital characteristics and geographic region? Antimicrob Agents Chemother 2016; 60:3170-3173.
[36]  Ogefere HO, Aigbiremwen PA and Omoregie R. Extended-Spectrum Beta-Lactamase (ESBL)-Producing Gram-negative Isolates from Urine and Wound Specimens in a Tertiary Health Facility in Southern Nigeria. Trop. Jour. Pharm Res 2015; 14 (6): 1089-1094.
[37]  Giwa FJ, Ige OT, Haruna DM, Yaqub Y, Lamido TZ and Usman SY. Extended spectrum beta lactamase production and antimicrobial susceptibility pattern of uropathogens in tertiary hospital in Northwestern Nigeria. Annals of Trop Pathol 2018; 9: 11-16.
[38]  Khan, S. A., Feroz, F. and Noor, R. Study of extended-spectrum b-lactamase-producing bacteria from urinary tract infections in Bangladesh. Tzu Chi Medical Journal 2013; 25: 39-42.
[39]  Latifpour M, Gholipour A and Damavandi MS. Prevalence of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolates in Nosocomial and Community-Acquired Urinary Tract Infections. Jundishapur Jour Microbiol 2016; 9(3), e31179.
[40]  Onanuga A and Selekere TL. Virulence and antimicrobial resistance of common urinary bacteria from asymptomatic students of Niger Delta University, Amassoma, Bayelsa State, Nigeria. Jour. Pharm Bioallied Sci 2016; 8(1), 29-33.